Raphael Pharmaceutical Inc.
RAPH
Rank in Stocks
#24796
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Share Price
$1.51
Last synced: 2026-11-06
Market Cap
$30.47M
Change (1 day)
0.00%
Change (1 year)
51.00%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Raphael Pharmaceutical Inc. (RAPH)
Category
Healthcare
Earnings for Raphael Pharmaceutical Inc. (RAPH)
Earnings in Jun 2026 TTM: $-980.00K
According to Raphael Pharmaceutical Inc.'s latest financial reports, its current earnings (TTM) are $-980.00K. In 2025 the company earned $-1.28M, an increase over its 2024 earnings of $-1.52M. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for Raphael Pharmaceutical Inc. from 2021 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $-980.00K | -23.38% |
| 2025 | $-1.28M | -15.80% |
| 2024 | $-1.52M | 13.02% |
| 2023 | $-1.34M | -59.98% |
| 2022 | $-3.36M | 106.77% |
| 2021 | $-1.62M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $3.59B | -366,688.30% |
DE
|
|
| $3.38B | -345,117.73% |
DE
|
|
| $2.53B | -258,635.50% |
JP
|
|
| $930.30M | -95,028.71% |
CH
|
|
| $381.32M | -39,009.77% |
IL
|
Questions about Raphael Pharmaceutical Inc.'s net income
What is Raphael Pharmaceutical Inc.'s net income?
Raphael Pharmaceutical Inc.'s net income over the last twelve months is $-980.00K, as of Jun 2026.
What was Raphael Pharmaceutical Inc.'s net income in 2025?
In 2025, Raphael Pharmaceutical Inc.'s net income was $-1.28M, compared with $-1.52M in 2024.
How has Raphael Pharmaceutical Inc.'s net income changed since 2021?
From 2021 to 2025, Raphael Pharmaceutical Inc.'s net income was highest in 2025 ($-1.28M) and lowest in 2022 ($-3.36M).
How does Raphael Pharmaceutical Inc.'s net income compare with similar companies?
Raphael Pharmaceutical Inc.'s net income ($-980.00K) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $3.59B.